Zomedica (NYSEAMERICAN:ZOM) Shares Down 0.7% – Should You Sell?

Zomedica Corp. (NYSEAMERICAN:ZOM)’s stock price was down 0.7% during trading on Friday . The stock traded as low as $0.12 and last traded at $0.12. Approximately 3,813,034 shares changed hands during trading, a decline of 31% from the average daily volume of 5,537,491 shares. The stock had previously closed at $0.12.

Wall Street Analysts Forecast Growth

Separately, Noble Financial raised Zomedica to a “strong-buy” rating in a research note on Monday, November 11th.

Zomedica Trading Down 0.7 %

The firm has a market cap of $117.40 million, a P/E ratio of -2.00 and a beta of 1.03.

Institutional Trading of Zomedica

Several large investors have recently added to or reduced their stakes in the stock. Jane Street Group LLC boosted its holdings in Zomedica by 199.8% in the 4th quarter. Jane Street Group LLC now owns 536,856 shares of the company’s stock worth $64,000 after acquiring an additional 357,782 shares during the period. Northern Trust Corp lifted its position in shares of Zomedica by 14.7% during the fourth quarter. Northern Trust Corp now owns 2,061,775 shares of the company’s stock worth $247,000 after purchasing an additional 263,873 shares in the last quarter. Two Sigma Securities LLC purchased a new position in shares of Zomedica in the fourth quarter valued at $32,000. Gabelli Funds LLC grew its holdings in Zomedica by 125.0% during the 4th quarter. Gabelli Funds LLC now owns 225,000 shares of the company’s stock valued at $27,000 after purchasing an additional 125,000 shares in the last quarter. Finally, Renaissance Technologies LLC acquired a new position in Zomedica in the 4th quarter worth $494,000. 8.95% of the stock is currently owned by institutional investors and hedge funds.

About Zomedica

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.